These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 37592042)

  • 1. Impaired renal autoregulation and pressure-natriuresis: any role in the development of heart failure in normotensive and angiotensin II-dependent hypertensive rats?
    Honetschlägerová Z; Sadowski J; Kompanowska-Jezierska E; Maxová H; Táborský M; Kujal P; Červenka L
    Hypertens Res; 2023 Oct; 46(10):2340-2355. PubMed ID: 37592042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal sympathetic denervation improves pressure-natriuresis relationship in cardiorenal syndrome: insight from studies with Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula.
    Honetschlägerová Z; Husková Z; Kikerlová S; Sadowski J; Kompanowska-Jezierska E; Táborský M; Vaňourková Z; Kujal P; Červenka L
    Hypertens Res; 2024 Apr; 47(4):998-1016. PubMed ID: 38302775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Sympathetic Denervation Attenuates Congestive Heart Failure in Angiotensin II-Dependent Hypertension: Studies with Ren-2 Transgenic Hypertensive Rats with Aortocaval Fistula.
    Honetschlagerová Z; Gawrys O; Jíchová Š; Škaroupková P; Kikerlová S; Vaňourková Z; Husková Z; Melenovský V; Kompanowska-Jezierska E; Sadowski J; Kolář F; Novotný J; Hejnová L; Kujal P; Červenka L
    Kidney Blood Press Res; 2021; 46(1):95-113. PubMed ID: 33530085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered Renal Vascular Responsiveness to Vasoactive Agents in Rats with Angiotensin II-Dependent Hypertension and Congestive Heart Failure.
    Vacková Š; Kikerlová S; Melenovsky V; Kolář F; Imig JD; Kompanowska-Jezierska E; Sadowski J; Červenka L
    Kidney Blood Press Res; 2019; 44(4):792-809. PubMed ID: 31430751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Renal Denervation on the Enhanced Renal Vascular Responsiveness to Angiotensin II in High-Output Heart Failure: Angiotensin II Receptor Binding Assessment and Functional Studies in Ren-2 Transgenic Hypertensive Rats.
    Honetschlägerová Z; Hejnová L; Novotný J; Marek A; Červenka L
    Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of pressure-natriuresis and renal autoregulation in ANG II-infused hypertensive rats.
    Wang CT; Chin SY; Navar LG
    Am J Physiol Renal Physiol; 2000 Aug; 279(2):F319-25. PubMed ID: 10919852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of soluble epoxide hydrolase counteracts the development of renal dysfunction and progression of congestive heart failure in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Červenka L; Melenovský V; Husková Z; Škaroupková P; Nishiyama A; Sadowski J
    Clin Exp Pharmacol Physiol; 2015 Jul; 42(7):795-807. PubMed ID: 25969338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antihypertensive action of soluble epoxide hydrolase inhibition in Ren-2 transgenic rats is mediated by suppression of the intrarenal renin-angiotensin system.
    Varcabova S; Huskova Z; Kramer HJ; Hwang SH; Hammock BD; Imig JD; Kitada K; Cervenka L
    Clin Exp Pharmacol Physiol; 2013 Apr; 40(4):273-81. PubMed ID: 23039246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impairment of the autoregulation of renal hemodynamics and of the pressure-natriuresis relationship precedes the development of hypertension in Cyp1a1-Ren-2 transgenic rats.
    Erbanová M; Thumová M; Husková Z; Vanecková I; Vanourková Z; Mullins JJ; Kramer HJ; Bürgelová M; Rakusan D; Cervenka L
    J Hypertens; 2009 Mar; 27(3):575-86. PubMed ID: 19330918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats.
    Honetschlägerová Z; Sporková A; Kopkan L; Husková Z; Hwang SH; Hammock BD; Imig JD; Kramer HJ; Kujal P; Vernerová Z; Chábová VC; Tesař V; Cervenka L
    J Hypertens; 2011 Aug; 29(8):1590-601. PubMed ID: 21720266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AT
    Kratky V; Vanourkova Z; Sykora M; Bacova BS; Hruskova Z; Kikerlova S; Huskova Z; Kopkan L
    Sci Rep; 2021 Feb; 11(1):4271. PubMed ID: 33608612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced renal vascular responsiveness to angiotensin II in hypertensive ren-2 transgenic rats.
    Jacinto SM; Mullins JJ; Mitchell KD
    Am J Physiol; 1999 Feb; 276(2):F315-22. PubMed ID: 9950963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasodilatory responses of renal interlobular arteries to epoxyeicosatrienoic acids analog are not enhanced in Ren-2 transgenic hypertensive rats: evidence against a role of direct vascular effects of epoxyeicosatrienoic acids in progression of experimental heart failure.
    Sporková A; Husková Z; Škaroupková P; Rami Reddy N; Falck JR; Sadowski J; Červenka L
    Physiol Res; 2017 Mar; 66(1):29-39. PubMed ID: 27782740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma and kidney angiotensin II levels and renal functional responses to AT(1) receptor blockade in hypertensive Ren-2 transgenic rats.
    Kopkan L; Kramer HJ; Husková Z; Vanourková Z; Bäcker A; Bader M; Ganten D; Cervenka L
    J Hypertens; 2004 Apr; 22(4):819-25. PubMed ID: 15126925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endothelin type A receptor blockade attenuates aorto-caval fistula-induced heart failure in rats with angiotensin II-dependent hypertension.
    Kala P; Gawrys O; Miklovič M; Vaňourková Z; Škaroupková P; Jíchová Š; Sadowski J; Kompanowska-Jezierska E; Walkowska A; Veselka J; Táborský M; Maxová H; Vaněčková I; Červenka L
    J Hypertens; 2023 Jan; 41(1):99-114. PubMed ID: 36204993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sex-linked differences in the course of chronic kidney disease and congestive heart failure: a study in 5/6 nephrectomized Ren-2 transgenic hypertensive rats with volume overload induced using aorto-caval fistula.
    Červenka L; Škaroupková P; Kompanowska-Jezierska E; Sadowski J
    Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):883-95. PubMed ID: 27385471
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of angiotensin-converting enzyme blockade, alone or combined with blockade of soluble epoxide hydrolase, on the course of congestive heart failure and occurrence of renal dysfunction in Ren-2 transgenic hypertensive rats with aorto-caval fistula.
    Kala P; Sedláková L; Škaroupková P; Kopkan L; Vaňourková Z; Táborský M; Nishiyama A; Hwang SH; Hammock BD; Sadowski J; Melenovský V; Imig JD; Červenka L
    Physiol Res; 2018 Jul; 67(3):401-415. PubMed ID: 29527914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced Renal Vascular Responsiveness to Angiotensin II and Norepinephrine: A Unique Feature of Female Rats with Congestive Heart Failure.
    Krátký V; Kikerlová S; Husková Z; Sadowski J; Kolář F; Červenka L
    Kidney Blood Press Res; 2019; 44(5):1128-1141. PubMed ID: 31505499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resetting of renal blood autoregulation during acute blood pressure reduction in hypertensive rats.
    Iversen BM; Kvam FI; Matre K; Ofstad J
    Am J Physiol; 1998 Aug; 275(2):R343-9. PubMed ID: 9688667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circadian rhythms in renal function in hypertensive TGR(mRen-2)27 rats and their normotensive controls.
    Pons M; Schnecko A; Witte K; Lemmer B; Waterhouse JM; Cambar J
    Am J Physiol; 1996 Oct; 271(4 Pt 2):R1002-8. PubMed ID: 8897993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.